Chronic Rhinosinusitis with Nasal Polyps
Clinical research in chronic rhinosinusitis with nasal polyps centers on improving control of nasal polyps and related upper-airway inflammation, with attention to symptom burden and endoscopic outcomes.
- Endoscopic nasal polyp score
- Nasal corticosteroid background therapy
- Upper airway inflammation
The sponsor is active in respiratory and inflammatory disease research with a focus on conditions affecting the nasal and sinus passages.
Severe Asthma
Studies in severe asthma examine disease control, asthma exacerbations, and long-term treatment tolerability in adults with persistent airway inflammation.
- Asthma exacerbation prevention
- Long-term safety
- Adult severe asthma
Research activity in this area reflects interest in difficult-to-control airway disease and outcomes relevant to ongoing respiratory management.
Chronic Obstructive Pulmonary Disease
Clinical trials in chronic obstructive pulmonary disease focus on reducing COPD exacerbations and improving overall disease control in adults with moderate-to-severe respiratory impairment.
- COPD exacerbations
- Moderate-to-severe COPD
- Airflow limitation
This area adds to the sponsor’s portfolio in chronic inflammatory and obstructive lung disorders.
Type 2 Inflammatory Airway Disease
The sponsor’s pipeline spans overlapping type 2 inflammatory airway conditions, including upper and lower respiratory tract disorders characterized by eosinophilic inflammation and recurrent symptoms.
- Eosinophilic airway inflammation
- Respiratory immunology
- Chronic inflammatory airway disorders
This research landscape connects asthma, COPD, and nasal polyposis within a shared therapeutic domain.
